Analyst IMS Investment Management Services’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.1M Buy
411,670
+405,600
+6,682% +$19.2M 0.46% 26
2025
Q4
$309K Buy
+6,070
New +$310K 0.01% 113
2024
Q4
Sell
-4,004
Closed -$477K 132
2024
Q3
$477K Hold
4,004
0.02% 109
2024
Q2
$571K Hold
4,004
0.02% 95
2024
Q1
$515K Buy
+4,004
New +$477K 0.02% 90

Other funds holding NVO

Analyst IMS Investment Management Services's NVO Position: Q1 2026 in Review

Analyst IMS Investment Management Services increased its Novo Nordisk (NVO) stake by 6,682% in Q1 2026, buying an estimated $19.2M and bringing the position to 411,670 shares worth $15.1M. The position accounts for 0.46% of the portfolio, ranked #26.

Analyst IMS Investment Management Services first reported a position in NVO in Q1 2024 and has held it in 5 quarters since. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Analyst IMS Investment Management Services held 411,670 shares of Novo Nordisk worth $15.1M as of Q1 2026.
  • Analyst IMS Investment Management Services bought 405,600 Novo Nordisk shares in Q1 2026, an estimated $19.2M.
  • Novo Nordisk made up 0.46% of Analyst IMS Investment Management Services's portfolio in Q1 2026, its #26 holding.
  • Analyst IMS Investment Management Services first reported a position in Novo Nordisk in Q1 2024 and has held it in 5 quarters since.
  • 1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Analyst IMS Investment Management Services's 13F filing for Q1 2026, filed 23 Apr 2026.